Table 5.

Mortality risk of patients with thrombocytopenia, relative to the general population

CharacteristicsRelative risk (95% CI)
Diagnosis  
 Initial diagnosis of ITP (n = 1505-1501.5  (1.1-2.2)  
 ITP (n = 138) 1.3  (0.9-2.0)  
 Reclassified as secondary TP (n = 12) 6.0  (2.5-15.0)  
Presenting symptoms  
 Severe thrombocytopenia (n = 122) 1.5  (1.0-2.2)  
 Moderate thrombocytopenia (n = 28) 1.9  (0.8-4.5)  
 Hemorrhagic symptoms (n = 128) 1.5  (1.1-2.2)  
 No hemorrhagic symptoms (n = 22) 1.7  (0.4-6.8) 
ITP depending on response to therapy5-151  
 Complete response (n = 90) 0.7  (0.4-1.3)  
 Partial response (n = 24) 1.8  (0.6-5.5)  
 Response to maintenance therapy (n = 8) 1.8  (0.6-5.5)  
 No response (n = 12) 4.2  (1.7-10.0) 
Referral  
 Primary (n = 73) 1.9  (1.1-3.0) 
 Secondary (n = 77) 1.3  (0.7-2.2) 
CharacteristicsRelative risk (95% CI)
Diagnosis  
 Initial diagnosis of ITP (n = 1505-1501.5  (1.1-2.2)  
 ITP (n = 138) 1.3  (0.9-2.0)  
 Reclassified as secondary TP (n = 12) 6.0  (2.5-15.0)  
Presenting symptoms  
 Severe thrombocytopenia (n = 122) 1.5  (1.0-2.2)  
 Moderate thrombocytopenia (n = 28) 1.9  (0.8-4.5)  
 Hemorrhagic symptoms (n = 128) 1.5  (1.1-2.2)  
 No hemorrhagic symptoms (n = 22) 1.7  (0.4-6.8) 
ITP depending on response to therapy5-151  
 Complete response (n = 90) 0.7  (0.4-1.3)  
 Partial response (n = 24) 1.8  (0.6-5.5)  
 Response to maintenance therapy (n = 8) 1.8  (0.6-5.5)  
 No response (n = 12) 4.2  (1.7-10.0) 
Referral  
 Primary (n = 73) 1.9  (1.1-3.0) 
 Secondary (n = 77) 1.3  (0.7-2.2) 

Mortality risks were estimated using the mortality rate ratio standardized for age, sex, and calendar time.

F5-150

Two patients were lost to follow-up.

F5-151

Response to therapy after 2 years of follow-up.

or Create an Account

Close Modal
Close Modal